219 related articles for article (PubMed ID: 19169878)
61. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.
Tian CH; Dai J; Zhang W; Liu Y; Yang Y
Medicine (Baltimore); 2019 Jun; 98(23):e15924. PubMed ID: 31169710
[TBL] [Abstract][Full Text] [Related]
62. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
[TBL] [Abstract][Full Text] [Related]
63. CYP2C19 Genotype Could be a Predictive Factor for Aggressive Manifestations of Hepatocellular Carcinoma Related with Chronic Hepatitis B Infection in Thailand.
Nun-Anan P; Chonprasertsuk S; Siramolpiwat S; Tangaroonsanti A; Bhanthumkomol P; Pornthisarn B; Vilaichone RK
Asian Pac J Cancer Prev; 2015; 16(8):3253-6. PubMed ID: 25921128
[TBL] [Abstract][Full Text] [Related]
64. Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma.
Li C; Bi X; Huang Y; Zhao J; Li Z; Zhou J; Zhang M; Huang Z; Zhao H; Cai J
PLoS One; 2014; 9(7):e101586. PubMed ID: 24987808
[TBL] [Abstract][Full Text] [Related]
65. Interleukin-21 receptor gene polymorphism is associated with hepatitis B virus-related hepatocellular carcinoma in Chinese patients.
Liu T; Song J; Zhang M; Li S; Zhang J; Hu X; Zhao Z; Peng W; Wu Q; Bai H; Li Y; Lu X; Ying B
J Clin Lab Anal; 2019 Jun; 33(5):e22860. PubMed ID: 30758075
[TBL] [Abstract][Full Text] [Related]
66. Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Li Y; Zhai Y; Song Q; Zhang H; Cao P; Ping J; Liu X; Guo B; Liu G; Song J; Zhang Y; Yang A; Yan H; Yang L; Cui Y; Ma Y; Xing J; Shen X; Liu T; Zhang H; An J; Bei JX; Jia W; Kang L; Liu L; Yuan D; Hu Z; Shen H; Lu L; Wang X; Li H; He F; Zhang H; Zhou G
Clin Cancer Res; 2018 Feb; 24(4):906-915. PubMed ID: 29246937
[No Abstract] [Full Text] [Related]
67. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.
Kim JH; Yu SJ; Park BL; Cheong HS; Pasaje CF; Bae JS; Lee HS; Shin HD; Kim YJ
Dig Dis; 2011; 29(3):278-83. PubMed ID: 21829018
[TBL] [Abstract][Full Text] [Related]
68. Association between TGF-β1 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Guo Y; Zang C; Li Y; Yuan L; Liu Q; Zhang L; Li S
Genet Test Mol Biomarkers; 2013 Nov; 17(11):814-20. PubMed ID: 24016252
[TBL] [Abstract][Full Text] [Related]
69. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
70. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
Wang P; Wu C; Li Y; Gong Y; Shen N
Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
[TBL] [Abstract][Full Text] [Related]
71. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer.
Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Avellini C; Minisini R; Pirisi M
Cytokine; 2008 Nov; 44(2):256-61. PubMed ID: 18809335
[TBL] [Abstract][Full Text] [Related]
72. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
[TBL] [Abstract][Full Text] [Related]
73. Role of IL-4 gene polymorphisms in HBV-related hepatocellular carcinoma in a Chinese population.
Lu Y; Wu Z; Peng Q; Ma L; Zhang X; Zhao J; Qin X; Li S
PLoS One; 2014; 9(10):e110061. PubMed ID: 25295591
[TBL] [Abstract][Full Text] [Related]
74. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
75. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yoon YJ; Chang HY; Ahn SH; Kim JK; Park YK; Kang DR; Park JY; Myoung SM; Kim DY; Chon CY; Han KH
Carcinogenesis; 2008 Jun; 29(6):1192-6. PubMed ID: 18390844
[TBL] [Abstract][Full Text] [Related]
76. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
[TBL] [Abstract][Full Text] [Related]
77. Correlation between the DEPDC5 rs1012068 polymorphism and the risk of HBV-related hepatocellular carcinoma.
Liu W; Ma N; Zhao D; Gao X; Zhang X; Yang L; Liu D
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):446-450. PubMed ID: 30683632
[TBL] [Abstract][Full Text] [Related]
78. Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population.
Xiang Y; Fan S; Cao J; Huang S; Zhang LP
Mol Biol Rep; 2012 Jun; 39(6):7019-23. PubMed ID: 22311030
[TBL] [Abstract][Full Text] [Related]
79. [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma].
Huang F; Hu LM; Liu JB; Zhang YX; Hu ZB
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1093-8. PubMed ID: 22336344
[TBL] [Abstract][Full Text] [Related]
80. The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai patients.
Sopipong W; Tangkijvanich P; Payungporn S; Posuwan N; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(5):2865-9. PubMed ID: 23803045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
